Medicaid program reforms, including telemedicine
Section 340B Drug Pricing Program
Sickle Cell Disease research funding generally
Drug pricing reforms generally
Reauthorization of Children's Hospital Graduate Medical Education program
Mental and behavioral health legislation generally
Children's Health Insurance Program (CHIP), regarding continuous eligibility
Autism CARES Act reauthorization - draft bill
Autism research programs and autism intervention programs generally
Department of Health and Human Services programs regarding autism and sickle cell disease research
Fiscal Year 2024 Department of Health and Human Services appropriations regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME) program, sickle cell disease research, Advanced Research Projects Agency-Health, and other programs related to pediatric health care
Duration: January 3, 2013
to
present
General Issues: Health Issues , Budget/Appropriations , Transportation , Medicare/Medicaid , Agriculture , Defense
Spending: about $5,864,694 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2013: U.S. Senate, House of Representatives, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Agency for Healthcare Research & Quality (AHRQ), Transportation - Dept of (DOT), Health & Human Services - Dept of (HHS), Executive Office of the President (EOP), Office of Management & Budget (OMB), U.S. Senate,, Education - Dept of
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on April 22.
Original Filing: 301573575.xml
Lobbying Issues
Medicaid program reforms, including telemedicine
Section 340B Drug Pricing Program
Sickle Cell Disease research funding generally
Drug pricing reforms generally
Reauthorization of Children's Hospital Graduate Medical Education program
Mental and behavioral health legislation generally
Children's Health Insurance Program (CHIP), regarding continuous eligibility
Autism CARES Act reauthorization - draft bill
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Autism research programs and autism intervention programs generally
Department of Health and Human Services programs regarding autism and sickle cell disease research
Fiscal Year 2024 Department of Health and Human Services appropriations regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME) program, sickle cell disease research, Advanced Research Projects Agency-Health, and other programs related to pediatric health care
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2023
In Q4, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on Jan. 23.
Original Filing: 301541628.xml
Lobbying Issues
Medicaid program reforms, including telemedicine
Section 340B Drug Pricing Program
Sickle Cell Disease research funding generally
Drug pricing reforms generally
Reauthorization of Children's Hospital Graduate Medical Education program
Mental and behavioral health legislation generally
Children's Health Insurance Program (CHIP), regarding continuous eligibility
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Autism research programs and autism intervention programs generally
Department of Health and Human Services programs regarding autism and sickle cell disease research
Fiscal Year 2024 Department of Health and Human Services appropriations regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME) program, sickle cell disease research, Advanced Research Projects Agency-Health, and other programs related to pediatric health care
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2023
In Q3, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on Oct. 20, 2023.
Original Filing: 301514174.xml
Lobbying Issues
Medicaid program reforms, including telemedicine
Section 340B Drug Pricing Program
Sickle Cell Disease research funding generally
Drug pricing reforms generally
Reauthorization of Children's Hospital Graduate Medical Education program
Mental and behavioral health legislation generally
Children's Health Insurance Program (CHIP), regarding continuous eligibility
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Autism research programs and autism intervention programs generally
Department of Health and Human Services programs regarding autism and sickle cell disease research
Fiscal Year 2024 Department of Health and Human Services appropriations regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME) program, sickle cell disease research, Advanced Research Projects Agency-Health, and other programs related to pediatric health care
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2023
In Q2, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on July 20, 2023.
Original Filing: 301490535.xml
Lobbying Issues
Medicaid program reforms, including telemedicine
Section 340B Drug Pricing Program
Sickle Cell Disease research funding generally
Drug pricing reforms generally
Reauthorization of Children's Hospital Graduate Medical Education program
Mental and behavioral health legislation generally
Children's Health Insurance Program (CHIP), regarding continuous eligibility
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Autism research programs and autism intervention programs generally
Department of Health and Human Services programs regarding autism and sickle cell disease research
Fiscal Year 2024 Department of Health and Human Services appropriations regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME) program, sickle cell disease research, Advanced Research Projects Agency-Health, and other programs related to pediatric health care
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2023
In Q1, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on April 19, 2023.
Original Filing: 301457977.xml
Lobbying Issues
Medicaid program reforms, including telemedicine
Section 340B Drug Pricing Program
Sickle Cell Disease research funding generally
Drug pricing reforms generally
Reauthorization of Children's Hospital Graduate Medical Education program
Mental and behavioral health legislation generally
Children's Health Insurance Program (CHIP), regarding continuous eligibility
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Autism research programs and autism intervention programs generally
Department of Health and Human Services programs regarding autism and sickle cell disease research
Fiscal Year 2024 Department of Health and Human Services appropriations regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME) program, sickle cell disease research, Advanced Research Projects Agency-Health, and other programs related to pediatric health care
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2022
In Q4, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on Jan. 20, 2023.
Original Filing: 301437164.xml
Lobbying Issues
Medicaid program reforms, including telemedicine
Section 340B Drug Pricing Program
Sickle Cell Disease research funding generally
Drug pricing reforms generally
Reauthorization of Children's Hospital Graduate Medical Education program
Mental and behavioral health legislation generally
H.R. 4943 (Children's Mental Health Infrastructure Act of 2021), all provisions
H.R. 4944 (Helping Kids Cope Act of 2021), all provisions
H.R. 5585 (Advanced Research Project Agency-Health Act), all provisions
H.R. 7236 (Strengthen Kids' Mental Health Now Act of 2022), all provisions
H.R. 7666 (Restoring Hope for Mental Health and Well-Being Act of 2022), all provisions
H.R. 6972 (Give Kids a Chance Act of 2022), all provisions
H.R. 7667 (Food and Drug Amendments of 2022), all provisions
H.R. 5131 and S. 2762 (PATCH Act), all provisions
H.R. 1916 (Ensuring Lasting Smiles Act), all provisions
S. 4348 (FDASLA Act of 2022), Title VIII, Subtitle C, regarding regulation of in vitro clinical tests
S. 4472 (Health Care Capacity for Pediatric Mental Health)
S. 4747 (Investing in Kids Mental Health Now Act)
Children's Health Insurance Program (CHIP), regarding continuous elgibility
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Autism research programs and autism intervention programs generally, including Department of Justice program on elopement
Department of Health and Human Services programs regarding autism and sickle cell disease research
H.R. 8295 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023) Title II, regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME) program, sickle cell disease research, and other programs related to pediatric health care
H.R. 2617 (Consolidated Appropriations Act, 2023), Division H, Title II, regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME) Program, sickle cell disease research, Advanced Research Projects Agency-Health,and other programs related to pediatric health care
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2022
In Q3, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on Oct. 19, 2022.
Original Filing: 301410320.xml
Lobbying Issues
Medicaid program reforms, including telemedicine
Section 340B Drug Pricing Program
Sickle Cell Disease research funding generally
Drug pricing reforms generally
Implementation of Children's Hospital Graduate Medical Education program
Mental and behavioral health legislation generally
H.R. 4943 (Children's Mental Health Infrastructure Act of 2021), all provisions
H.R. 4944 (Helping Kids Cope Act of 2021), all provisions
H.R. 6000 (Cures 2.0 Act of 2021), all provisions
H.R. 5585 (Advanced Research Project Agency-Health Act), all provisions
H.R. 7236 (Strengthen Kids' Mental Health Now Act of 2022), all provisions
H.R. 7666 (Restoring Hope for Mental Health and Well-Being Act of 2022), all provisions
H.R. 6972 (Give Kids a Chance Act of 2022), all provisions
H.R. 7667 (Food and Drug Amendments of 2022), all provisions
H.R. 5131 and S. 2762 (PATCH Act), all provisions
S. 4348 (FDASLA Act of 2022), Title VIII, Subtitle C, regarding regulation of in vitro clinical tests
S. 4472 (Health Care Capacity for Pediatric Mental Health)
S. 4747 (Investing in Kids Mental Health Now Act)
Medicaid reimbursement for stroke screening in children with Sickle Cell Disease, generally
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS) Agency for Healthcare Research & Quality (AHRQ)
Lobbying Issues
Autism research programs and autism intervention programs generally, including Department of Justice program on elopement
Department of Health and Human Services programs regarding autism and sickle cell disease research
H.R. 8295 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023) Title II, regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME) program, sickle cell disease research, and other programs related to pediatric health care
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2022
In Q2, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on July 20, 2022.
Original Filing: 301392377.xml
Lobbying Issues
Medicaid program reforms, including telemedicine
Section 340B Drug Pricing Program
Sickle Cell Disease research funding generally
Drug pricing reforms generally
Implementation of Children's Hospital Graduate Medical Education program
Mental and behavioral health legislation generally
H.R. 4943 (Children's Mental Health Infrastructure Act of 2021), all provisions
H.R. 4944 (Helping Kids Cope Act of 2021), all provisions
H.R. 6000 (Cures 2.0 Act of 2021), all provisions
H.R. 5585 (Advanced Research Project Agency-Health Act), all provisions
H.R. 7236 (Strengthen Kids' Mental Health Now Act of 2022), all provisions
H.R. 7666 (Restoring Hope for Mental Health and Well-Being Act of 2022), all provisions
H.R. 3773 (PACT Act of 2021), all provisions
H.R. 6972 (Give Kids a Chance Act of 2022), all provisions
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Autism research programs and autism intervention programs generally, including Department of Justice program on elopement
Department of Health and Human Services programs regarding autism and sickle cell disease research
H.R. 8295 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023) Title II, regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME) program, sickle cell disease research, and other programs related to pediatric health care
H.R. 5376 (Build Back Better Act), Sections 30801, 31002, and 31008, regarding CHIP program, CHGME program, and hospital infrastructure
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2022
In Q1, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on April 20, 2022.
Original Filing: 301364591.xml
Lobbying Issues
Medicaid program reforms, including telemedicine
Section 340B Drug Pricing Program
Sickle Cell Disease research funding generally
Drug pricing reforms generally
Implementation of Children's Hospital Graduate Medical Education program
Mental and behavioral health legislation generally
S. 1902 (Behavioral Health Crisis Services Expansion Act), all provisions
H.R. 4943 (Children's Mental Health Infrastructure Act of 2021), all provisions
H.R. 4944 (Helping Kids Cope Act of 2021), all provisions
H.R. 6000 (Cures 2.0 Act of 2021), all provisions
H.R. 5585 (Advanced Research Project Agency-Health Act), all provisions
S. 3704 (ASSIST Act), all provisions
H.R. 7236 (Strengthen Kids' Mental Health Now Act of 2022), all provisions
H.R. 5131 and S. 2762 (Pediatric Access to Critical Healthcare (PATCH) Act), all provisions
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Autism research programs and autism intervention programs generally, including Department of Justice program on elopement
Department of Health and Human Services programs regarding autism and sickle cell disease research
H.R. 4502 (Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2022), Title II, regarding National Institutes of Health funding, Children's Graduate Medical Education program, sickle cell disease research, and other programs related to pediatric health care
H.R. 5376 (Build Back Better Act), Sections 30801, 31002, and 31008, regarding CHIP program, CHGME program, and hospital infrastructure
Fiscal Year 2023 appropriations for Department of Health and Human Services
H.R. 2471 (Consolidated Appropriations Act, 2022), Division H, Title II, regarding National Institutes of Health funding, CHGME program, sickle cell disease research, and other programs related to pediatric health care
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2021
In Q4, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on Jan. 19, 2022.
Original Filing: 301328207.xml
Lobbying Issues
Implementation of health care reform generally pertaining to pediatric health care and autism services
Medicaid program reforms, including telemedicine
Section 340B Drug Pricing Program
Sickle Cell Disease research funding generally
Drug pricing reforms generally
Implementation of Children's Hospital Graduate Medical Education program
Mental and behavioral health legislation generally
S. 1902 (Behavioral Health Crisis Services Expansion Act), all provisions
H.R. 4943 (Children's Mental Health Infrastructure Act of 2021), all provisions
H.R. 4944 (Helping Kids Cope Act of 2021), all provisions
H.R. 5131 and S. 2762 (Pediatric Access to Critical Healthcare (PATCH) Act), all provisions
Draft 21st Century Cures Act 2.0, regarding regulation of new biomedical products and technologies
H.R. 5585 (Advanced Research Project Agency-Health Act), all provisions
S. 3139 (Healthy Competition for Better Care Act), all provisions
Implementation of 'No Surprises Act'
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Autism research programs and autism intervention programs generally, including Department of Justice program on elopement
Department of Defense programs regarding autism research
Department of Health and Human Services programs regarding autism and sickle cell disease research
H.R. 4502 (Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2022), Title II, regarding National Institutes of Health funding, Children's Graduate Medical Education program, sickle cell disease research, and other programs related to pediatric health care
H.R. 5376 (Build Back Better Act), Sections 30801, 31002, and 31008, regarding CHIP program, CHGME program, and hospital infrastructure
H.R. 6119 (Further Extending Government Funding Act), all provisions
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2021
In Q3, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on Oct. 19, 2021.
Original Filing: 301303505.xml
Lobbying Issues
Implementation of health care reform generally pertaining to pediatric health care and autism services
Medicaid program reforms, including telemedicine
Section 340B Drug Pricing Program
Sickle Cell Disease research funding generally
Drug pricing reforms generally
Implementation of Children's Hospital Graduate Medical Education program
Mental and behavioral health legislation generally
S. 1902 (Behavioral Health Crisis Services Expansion Act), all provisions
H.R. 4944 (Helping Kids Cope Act of 2021), all provisions
H.R. 5131 and S. 2762 (Pediatric Access to Critical Healthcare (PATCH) Act), all provisions
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Autism research programs and autism intervention programs generally, including Department of Justice program on elopement
Department of Defense programs regarding autism research
Department of Health and Human Services programs regarding autism and sickle cell disease research
H.R. 4502 (Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2022), Title II, regarding National Institutes of Health funding, Children's Graduate Medical Education program, sickle cell disease research, and other programs related to pediatric health care
H.R. 5376 (Build Back Better Act), Sections 30801, 31002, and 31008, regarding CHIP program, CHGME program, and hospital infrastructure
H.R. 5305 (Extending Government Funding and Delivering Emergency Assistance Act), all provisions
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2021
Children's Healthcare of Atlanta amended a lobbying report for in-house lobbying in Q32021 on Oct. 19, 2021
Original Filing: 301303539.xml
Lobbying Issues
Implementation of health care reform generally pertaining to pediatric health care and autism services
Medicaid program reforms, including telemedicine
Section 340B Drug Pricing Program
Sickle Cell Disease research funding generally
Drug pricing reforms generally
Implementation of Children's Hospital Graduate Medical Education program
Mental and behavioral health legislation generally
S. 1902 (Behavioral Health Crisis Services Expansion Act), all provisions
H.R. 4944 (Helping Kids Cope Act of 2021), all provisions
H.R. 5131 and S. 2762 (Pediatric Access to Critical Healthcare (PATCH) Act), all provisions
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Autism research programs and autism intervention programs generally, including Department of Justice program on elopement
Department of Defense programs regarding autism research
Department of Health and Human Services programs regarding autism and sickle cell disease research
H.R. 4502 (Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2022), Title II, regarding National Institutes of Health funding, Children's Graduate Medical Education program, sickle cell disease research, and other programs related to pediatric health care
H.R. 5376 (Build Back Better Act), Sections 30801, 31002, and 31008, regarding CHIP program, CHGME program, funding for zero emission buses, and hospital infrastructure
H.R. 5305 (Extending Government Funding and Delivering Emergency Assistance Act), all provisions
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2021
In Q2, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on July 20, 2021.
Original Filing: 301290099.xml
Lobbying Issues
Implementation of health care reform generally pertaining to pediatric health care and autism services
Medicaid program reforms, including telemedicine
Section 340B Drug Pricing Program
Sickle Cell Disease research funding generally
Drug pricing reforms generally
Organ transplant policy generally, including liver transplant distribution methodology
Implementation of Children's Hospital Graduate Medical Education program
Mental and behavioral health legislation generally, including S. 1902 (Behavioral Health Crisis Services Expansion Act), all provisions
CMS policies related to COVID-19 patients
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Autism research programs and autism intervention programs generally, including Department of Justice program on elopement
Department of Defense programs regarding autism research
Department of Health and Human Services programs regarding autism and sickle cell disease research
Fiscal Year 2022 Department of Health and Human Services appropriations regarding National Institutes of Health funding, Children's Graduate Medical Education program, sickle cell disease research, and other programs related to pediatric health care
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2021
In Q1, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on April 19, 2021.
Original Filing: 301257449.xml
Lobbying Issues
Implementation of health care reform generally pertaining to pediatric health care and autism services
Medicaid program reforms, including telemedicine and Medicaid Fiscal Accountability Regulation
Section 340B Drug Pricing Program
Sickle Cell Disease research funding generally
Drug pricing reforms generally
Organ transplant policy generally, including liver transplant distribution methodology
Implementation of Children's Hospital Graduate Medical Education program
Mental and behavioral health legislation generally
CMS policies related to COVID-19 patients
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Autism research programs and autism intervention programs generally, including Department of Justice program on elopement
Department of Defense programs regarding autism research
Department of Health and Human Services programs regarding autism and sickle cell disease research
Fiscal Year 2022 Department of Health and Human Services appropriations regarding National Institutes of Health funding, Children's Graduate Medical Education program, sickle cell disease research, and other programs related to pediatric health care
H.R. 1319 (American Rescue Plan Act of 2021), Titles II and IX, regarding Health and Human Services funding
H.R. 1848 (LIFT America Act), Title IV, regarding hospital funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2020
In Q4, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on Jan. 20, 2021.
Original Filing: 301238119.xml
Lobbying Issues
Implementation of health care reform generally pertaining to pediatric health care and autism services
Medicaid program reforms, including telemedicine and Medicaid Fiscal Accountability Regulation
Section 340B Drug Pricing Program
Sickle cell disease research funding generally
Drug pricing reforms generally, including H.R. 3 (Lower Drug Costs Now Act of 2019), all provisions
Organ transplant policy generally, including liver transplant distribution methodology
S. 1895 (Lower Health Care Costs Act), Title I, regarding hospital billing practices
H.R. 2328 (REACH Act), Title IV, regarding hospital billing practices
Implementation of Children's Hospital Graduate Medical Education program
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Autism research programs and autism intervention programs generally
Department of Education special education programs regarding autism
Department of Health and Human Services programs regarding autism and sickle cell disease research
H.R. 7614 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021), Title II, regarding National Institute of Health funding, Children's Hospitals Graduate Medical Education program, sickle cell disease research, and other programs related to pediatric health care
Implementation of the CARES Act regarding hospital funding
S. 4108 (Coronavirus Medicaid Response Act), all provisions
H.R. 133 (Consolidated Appropriations Act, 2021), Divisions H and M, regarding Health and Human Services funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2020
In Q3, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on Oct. 19, 2020.
Original Filing: 301214158.xml
Lobbying Issues
Implementation of health care reform generally pertaining to pediatric health care and autism services
Medicaid program reforms, including telemedicine and Medicaid Fiscal Accountability Regulation
Section 340B Drug Pricing Program
Sickle cell disease research funding generally
Drug pricing reforms generally, including H.R. 3 (Lower Drug Costs Now Act of 2019), all provisions
Organ transplant policy generally, including liver transplant distribution methodology
S. 1895 (Lower Health Care Costs Act), Title I, regarding hospital billing practices
H.R. 2328 (REACH Act), Title IV, regarding hospital billing practices
Implementation of Children's Hospital Graduate Medical Education program
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Autism research programs and autism intervention programs generally
Department of Education special education programs regarding autism
Department of Health and Human Services programs regarding autism and sickle cell disease research
H.R. 7614 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021), Title II, regarding National Institute of Health funding, Children's Hospitals Graduate Medical Education program, sickle cell disease research, and other programs related to pediatric health care
Implementation of the CARES Act regarding hospital funding
S. 4108 (Coronavirus Medicaid Response Act), all provisions
H.R. 6800 (The Heroes Act), all provisions
H.R. 925 (The Heroes Act), all provisions
Senate coronavirus-related bills (HEALS Act), all provisions
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2020
Children's Healthcare of Atlanta amended a lobbying report for in-house lobbying in Q22020 on July 20, 2020
Original Filing: 301196388.xml
Lobbying Issues
Implementation of health care reform generally pertaining to pediatric health care and autism services
Medicaid program reforms, including hospital outpatient department regulations and Medicaid Fiscal Accountability Regulation
Section 340B Drug Pricing Program
Sickle cell disease research funding generally
Drug pricing reforms generally, including H.R. 3 (Lower Drug Costs Now Act of 2019), all provisions
Organ transplant policy generally, including liver transplant distribution methodology
S. 1895 (Lower Health Care Costs Act), Title I, regarding hospital billing practices
H.R. 2328 (REACH Act), Title IV, regarding hospital billing practices
Implementation of Children's Hospital Graduate Medical Education program
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Autism research programs and autism intervention programs generally
Department of Education special education programs regarding autism
Department of Health and Human Services programs regarding autism and sickle cell disease research
Fiscal Year 2021 Health and Human Services appropriations regarding National Institute of Health funding, Children's Hospitals Graduate Medical Education program, sickle cell disease research, and other programs related to pediatric health care
Implementation of the CARES Act regarding hospital funding
S. 4108 (Coronavirus Medicaid Response Act), all provisions
H.R. 6800 (The Heroes Act), all provisions
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2020
In Q2, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on July 17, 2020.
Original Filing: 301190870.xml
Lobbying Issues
Implementation of health care reform generally pertaining to pediatric health care and autism services
Medicaid program reforms, including hospital outpatient department regulations and Medicaid Fiscal Accountability Regulation
Section 340B Drug Pricing Program
Sickle cell disease research funding generally
Drug pricing reforms generally, including H.R. 3 (Lower Drug Costs Now Act of 2019), all provisions
Organ transplant policy generally, including liver transplant distribution methodology
S. 1895 (Lower Health Care Costs Act), Title I, regarding hospital billing practices
H.R. 2328 (REACH Act), Title IV, regarding hospital billing practices
Implementation of Children's Hospital Graduate Medical Education program
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Autism research programs and autism intervention programs generally
Department of Education special education programs regarding autism
Department of Health and Human Services programs regarding autism and sickle cell disease research
Fiscal Year 2021 Health and Human Services appropriations regarding National Institute of Health funding, Children's Hospitals Graduate Medical Education program, sickle cell disease research, and other programs related to pediatric health care
Implementation of the CARES Act regarding hospital funding
S. 4108 (Coronavirus Medicaid Response Act), all provisions
H.R. 6800 (The Heroes Act), all provisions
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2020
In Q1, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on April 17, 2020.
Original Filing: 301170172.xml
Lobbying Issues
Implementation of health care reform generally pertaining to pediatric health care and autism services
Medicaid program reforms, including hospital outpatient department regulations and Medicaid Fiscal Accountability Regulation
Section 340B Drug Pricing Program
Sickle cell disease research funding generally
Drug pricing reforms generally, including H.R. 3 (Lower Drug Costs Now Act of 2019), all provisions
Department of Justice implementation of grant program for missing individuals with autism and developmental disabilities
Organ transplant policy generally, including liver transplant distribution methodology
Reauthorization of Child Abuse Prevention And Treatment Act (CAPTA) programs, including S. 2971 (CAPTA Reauthorization Act of 2019), all provisions
S. 1895 (Lower Health Care Costs Act), Title I, regarding hospital billing practices
H.R. 2328 (REACH Act), Title IV, regarding hospital billing practices
Implementation of Children's Hospital Graduate Medical Education program
H.R. 4519 (Pediatricians Accelerate Childhood Therapies Act of 2019), all provisions
H.R. 3935 (Protecting Patients Transportation to Care Act of 2019), all provisions
H.R. 4801 (Healthy Start Reauthorization Act of 2019), all provisions
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Autism research programs and autism intervention programs generally
Department of Education special education programs regarding autism
Department of Health and Human Services programs regarding autism and sickle cell disease research
Fiscal Year 2021 Health and Human Services appropriations regarding National Institute of Health funding, Children's Hospitals Graduate Medical Education program, sickle cell disease research, and other programs related to pediatric health care
H.R. 748 and S. 3548 (CARES Act), Division B, regarding hospital funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives U.S. Senate
4th Quarter, 2019
In Q4, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on Jan. 17, 2020.
Original Filing: 301109806.xml
Lobbying Issues
Autism research programs and autism intervention programs generally
Department of Education special education programs regarding autism
Department of Health and Human Services programs regarding autism and sickle cell disease research
H.R. 2740 (Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020), Division A, Title II, regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education program, sickle cell disease research, and other programs related to pediatric healthcare
H.R. 1865 (Further Consolidated Appropriations Act, 2020), Division A, Title II, regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education program, sickle cell disease research, and other programs related to pediatric healthcare
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Implementation of health care reform generally pertaining to pediatric health care and autism services
Medicaid program reforms, including hospital outpatient department regulations and Medicaid Fiscal Accountability Regulation
Section 340B Drug Pricing Program
Sickle cell disease research funding generally
Drug pricing reforms generally, including H.R. 3 (Lower Drug Costs Now Act of 2019), all provisions
Department of Justice implementation of grant program for missing individuals with autism and developmental disabilities
Organ transplant policy generally, including liver transplant distribution methodology
Reauthorization of Child Abuse Prevention And Treatment Act (CAPTA) programs, including S. 2971 (CAPTA Reauthorization Act of 2019), all provisions
S. 1895 (Lower Health Care Costs Act), Title I, regarding hospital billing practices
H.R. 2328 (REACH Act), Title IV, regarding hospital billing practices
Implementation of Children's Hospital Graduate Medical Education program
H.R. 4519 (Pediatricians Accelerate Childhood Therapies Act of 2019), all provisions
H.R.4439 (Creating Hope Reauthorization Act), all provisions
H.R.2581 (Nurse Staffing Standards for Hospital Patient Safety and Quality Care Act of 2019), all provisions
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Georgia Department of Transportation Interchange Modification Report regarding an intersection on Interstate 85
Agencies Lobbied
U.S. Senate Transportation - Dept of (DOT)
3rd Quarter, 2019
In Q3, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on Oct. 21, 2019.
Original Filing: 301074835.xml
Lobbying Issues
Autism Research programs and Autism Intervention Programs generally
Department of Education Special education programs regarding Autism
Department of Health and Human Services Programs regarding Autism and Sickle Cell Disease Research
H.R. 1058 and S.427 (Autism CARES Act of 2019), all provisions
H.R. 2740 (Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020), Division A, Title II, Regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education program, Sickle Cell disease research, and other programs related to pediatric healthcare
H.R. 4378 (Continuing Appropriations Act, 2020, and Health Extenders Act of 2019), Division A, regarding HHS appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Implementation of Health care reform generally pertaining to pediatric healthcare and autism services
Medicaid program reforms, including hospital outpatient department regulations
Section 340B Drug Pricing Program
Sickle Cell disease research funding generally
drug pricing reforms generally, including H.R. 3 (Lower Drug Costs Now Act of 2019). all provisions
department of Justice Implementation of grant program for missing individuals with autism and Developmental disabilities
Organ transplant policy generally, including liver transplant distribution methodology
Reauthorization of Child Abuse Prevention And Treatment Act (CAPTA) Programs
S. 1895 (Lower Health Care Costs Act), title I, regarding hospital billing practices
H.R. 2328 (REACH act), Title IV, regarding hospital billing practices
Department of Homeland Security "public charge" rule regarding access to Medicaid benefits
implementation of Children's Hospital Graduate Medical Education program
H.R.2581 (Nurse Staffing Standards for Hospital Patient Safety and Quality Care Act of 2019)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2019
In Q2, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on July 22, 2019.
Original Filing: 301054638.xml
Lobbying Issues
Autism Research programs and Autism Intervention Programs generally
Department of Education Special education programs regarding Autism
Department of Health and Human Services Programs regarding Autism and Sickle Cell Disease Research
H.R. 1058 and S.427 (Autism CARES Act of 2019), all provisions
H.R. 2740 (Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020), Division A, Title II, Regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education program, Sickle Cell disease research, and other programs related to pediatric healthcare
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Implementation of Health care reform generally pertaining to pediatric healthcare and autism services
Medicaid program reforms, including hospital outpatient department regulations
Section 340B Drug Pricing Program
Sickle Cell disease research funding generally
drug pricing reforms generally
department of Justice Implementation of grant program for missing individuals with autism and Developmental disabilities
Organ transplant policy generally, including liver transplant distribution methodology
Reauthorization of Child Abuse Prevention And Treatment Act (CAPTA) Programs
H.R. 2076 and S. 1009 (Early Detection to Stop Infant Abuse and Prevent Fatalities Act), all provisions
S. 1895 (Lower Health Care Costs Act) and House draft No Surprises Act, regarding hospital billing practices
H.R.1618 (Nicholas and Zachary Burt Carbon Monoxide Poisoning Prevention Act), all provisions
S.427 and H.R.1058 (Autism CARES Act), all provisions
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2019
In Q1, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on April 22, 2019.
Original Filing: 301034754.xml
Lobbying Issues
Autism Research programs and Autism Intervention Programs generally
Department of Education Special education programs regarding Autism
Department of Health and Human Services Programs regarding Autism and Sickle Cell Disease Research
H.R. 1058 and S.427 (Autism CARES Act of 2019), all provisions
FY 2020 Department of Health and Human Services appropriations regarding National Institute of Health Funding, Children's Hospital Graduate Medical Education Program, sickle cell disease research, and other programs related to pediatric healthcare
H.J. Res. 31 (Consolidated Appropriations Act, 2019), regarding federal funding generally
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Implementation of Health care reform generally pertaining to pediatric healthcare and autism services
Medicaid program reforms, including hospital outpatient department regulations
Section 340B Drug Pricing Program
Sickle Cell disease research funding generally
drug pricing reforms generally
department of Justice Implementation of grant program for missing individuals with autism and Developmental disabilities
Organ transplant policy generally, including liver transplant distribution methodology
legislation regarding hospital billing practices
H.R. 1839 (Medicaid services investment and accountability act of 2019), Section 3, regarding Medicaid reimbursement for medically complex children
Reauthorization of Child Abuse Prevention And Treatment Act (CAPTA) Programs
H.R. 2076 and S. 1009 (Early Detection to Stop Infant Abuse and Prevent Fatalities Act), all provisions
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2018
In Q4, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on Jan. 22, 2019.
Original Filing: 301014208.xml
Lobbying Issues
Autism Research programs and autism intervention programs generally
Department of Education special education programs regarding autism
Department of Health and Human Services programs regarding autism and sickle cell disease research
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
implementation of health care reform generally pertaining to pediatric health care and autism services
Medicaid program reforms, including hospital outpatient department regulations
S.3770 (Medicaid Drug Decisions Transparency Act), all provisions
Section 340B Drug Pricing Program, including H.R. 4710 (340B PAUSE Act), All provisions, and H.R. 5598 (340B Optimization Act), all provisions and H.R. 6240 (drug Discount accountability act), all provisions
Sickle Cell Disease Research funding generally
Drug pricing reforms generally
Department of Justice implementation of grant program for missing individuals with autism and developmental disabilities
Department of Homeland Security rulemaking regarding public charge rule and Medicaid program implications
S. 3429 (Neonatal Abstinence Intervention Act), all provisions
H.R. 2410 (Sickle Cell Disease research, Surveillance, prevention and treatment act of 2017), all provisions
S. 2465 (Sickle cell disease and other heritable blood disorders research, surveillance, Prevention and treatment act of 2018), all provisions
H.R. 3325 (ACE kids Act), all provisions
S. 428 (Ace Kids Act of 2017), all provisions
H.R. 1676 (Palliative Care and Hospice Education and Training Act), all provisions
Organ Transplant policy generally, including transplant distribution methodology
H.R. 7217 (Improving Medicaid Programs and Opportunities for Eligible Beneficiaries Act - IMPROVE act), Title I, regarding coordinated care
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2018
In Q3, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on Oct. 22, 2018.
Original Filing: 300996932.xml
Lobbying Issues
Autism Research programs and autism intervention programs generally
Department of Education special education programs regarding autism
Department of Health and Human Services programs regarding autism and sickle cell disease research
H.R. 6470 and S. 3158 (Departments of Labor, Health and Human Services, and education, and related agencies appropriations act, 2019) regarding National Institutes of Health funding level, Children's Hospital Graduate Medical Education Program, sickle cell disease, and other programs related to Pediatric Healthcare
H.R. 6157 (Department of Defense and Labor, Health and Human Services and education Appropriations act, 2019 and Continuing Appropriations act, 2019)Division B, Title II regarding HHS appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
implementation of health care reform generally pertaining to pediatric health care and autism services
Medicaid program reforms, including hospital outpatient department regulations
Section 340B Drug Pricing Program, including H.R. 4710 (340B PAUSE Act), All provisions, and H.R. 5598 (340B Optimization Act), all provisions and H.R. 6240 (drug Discount accountability act), all provisions
H.R. 5385 (Dr. Benjy Frances Brooks Children's Hospital GME Support Reauthorization Act of 2018), all provisions
S. 2597 (Children's Hospital GME Support Reauthorization act of 2018), all provisions
Sickle Cell Disease Research funding generally
Drug pricing reforms generally
Department of Justice implementation of grant program for missing individuals with autism and developmental disabilities
H.R. 6560 (ChiPACC Act of 2018), all provisions
Department of Homeland Security rulemaking regarding public charge rule and Medicaid program implications
S. 3429 (Neonatal Abstinence Intervention Act), all provisions
H.R. 2410 (Sickle Cell Disease research, Surveillance, prevention and treatment act of 2017), all provisions
S. 2465 (Sickle cell disease and other heritable blood disorders research, surveillance, Prevention and treatment act of 2018), all provisions
H.R. 6 (support for patients and Communities Act), section 1004 regarding Medicaid drug review and utilization
H.R. 6458 (National Organ Transplant Act Amendments of 2018), all provisions
H.R. 3325 (ACE kids Act), all provisions
S. 428 (Ace Kids Act of 2017), all provisions
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2018
Children's Healthcare of Atlanta amended a lobbying report for in-house lobbying in Q22018 on July 24, 2018
Original Filing: 300979269.xml
Lobbying Issues
Autism Research programs and autism intervention programs generally
Department of Education special education programs regarding autism
Department of Health and Human Services programs regarding autism and sickle cell disease research
S. 3158 and House Companion bill (departments of Labor, Health and Human Services, and education, and related Agencies Appropriations Act, 2019), related to pediatric healthcare
H.R. 3 (Spending cuts to expired and unnecessary programs act), section2, provisions related to Children's Health Insurance Program
H.R.5961 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2019, regarding regulation of tobacco products generally
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
implementation of health care reform generally pertaining to pediatric health care and autism services
Medicaid program reforms, including hospital outpatient department regulations
Section 340B Drug Pricing Program, including H.R. 4710 (340B PAUSE Act), All provisions, and H.R. 5598 (340B Optimization Act), all provisions
H.R. 5385 and S. 2597 (Children's Hospital GME Support Reauthorization act of 2018), all provisions
Sickle Cell Disease Research funding generally
Drug pricing reforms generally
Department of Justice implementation of grant program for missing individuals with autism and developmental disabilities
draft legislation regarding neonatal Abstinence Syndrome and Medicaid coverage
Opioid Regulation Generally
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2018
In Q2, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on July 20, 2018.
Original Filing: 300974800.xml
Lobbying Issues
Autism Research programs and autism intervention programs generally
Department of Education special education programs regarding autism
Department of Health and Human Services programs regarding autism and sickle cell disease research
S. 3158 and House Companion bill (departments of Labor, Health and Human Services, and education, and related Agencies Appropriations Act, 2019), related to pediatric healthcare
H.R. 3 (Spending cuts to expired and unnecessary programs act), section2, provisions related to Children's Health Insurance Program
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
implementation of health care reform generally pertaining to pediatric health care and autism services
Medicaid program reforms, including hospital outpatient department regulations
Section 340B Drug Pricing Program, including H.R. 4710 (340B PAUSE Act), All provisions, and H.R. 5598 (340B Optimization Act), all provisions
H.R. 5385 and S. 2597 (Children's Hospital GME Support Reauthorization act of 2018), all provisions
Sickle Cell Disease Research funding generally
Drug pricing reforms generally
Department of Justice implementation of grant program for missing individuals with autism and developmental disabilities
draft legislation regarding neonatal Abstinence Syndrome and Medicaid coverage
Food and Drug Administration, regarding H.R. 1256 (The Tobacco Control Act)
H.R. 5684 (the Protecting Seniors from Opioid Abuse Act)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2018
In Q1, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on April 20, 2018.
Original Filing: 300953826.xml
Lobbying Issues
Autism Research programs and Autism intervention programs generally
Department of Education special education programs regarding Autism
Department of Health and Human Services programs regarding Autism and sickle cell disease research
H.R. 1625 (Consolidated Appropriations Act, 2018), Division H- Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations Act, 2018 regarding autism diagnosis and treatment programs, Children's Hospital Graduate Medical Education Program, National Institutes of Health and sickle cell disease
FY '19 Health and Human Services appropriations regarding National Institute of Health funding level, Children's Hospital Graduate Medical Education program, sickle cell disease and other programs related to pediatric healthcare
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
implementation of health care reform generally pertaining to pediatric health care and autism services
Medicaid program reforms, including hospital outpatient department regulations
Section 340B Drug Pricing Program, including H.R. 195 (Making further continuing appropriations for the fiscal year ending September 30, 2018, and for other purposes), Division C - Healthy Kids Act, and H.R. 1892 (Bipartisan Budget Act of 2018), Division E- Access Act, Section 50101
H.R. 1625 (Consolidated Appropriations Act, 2018) Division Q - Kevin and Avonte's law, regarding grants and standards for missing individuals with autism and developmental disabilities
S.256 and H.R. 767 (SOAR to Health and Wellness Act of 2017), all provisions, and federal policy regarding human trafficking
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2017
In Q4, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on Jan. 19, 2018.
Original Filing: 300928166.xml
Lobbying Issues
Autism Research programs and Autism intervention programs generally
Department of Education special education programs regarding Autism
Department of Health and Human Services programs regarding Autism, hospital acquired infections and sickle cell disease research
H.R. 3358 and S. 1771 (Departments of Labor, Health and Human Services, and Education, and related Agencies Appropriations Act, 2018), regarding autism diagnosis and treatment programs, Children's Hospital Graduate Medical Education program, National Institutes of Health and sickle cell disease
H.R. 1370, Continuing Resolution, regarding Health and Human Services appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
implementation of health care reform generally pertaining to pediatric health care and autism services
Medicaid program reforms, including hospital outpatient department regulations
Section 340B Drug Pricing Program
Federal Policy regarding United Network for Organ Sharing (UNOS) and allocation of donated organs
Reauthorization of Children's Hospital Graduate Medical Education program
Sickle Cell Disease research funding generally
Reauthorization of Children's Health Insurance Program, including H.R. 3922 (Championing Healthy Kids act), Division B, Title I
Youth suicide prevention and mental health programs generally
Prevention of sudden cardiac arrest, including the Cardiomyopathy Health Education, Awareness, Research, and Training in the Schools (HEARTS) Act of 2017 (H.R. 3880) and Advocating Education on Defibrillation in our Schools (AEDs) Resolution (H.Res. 35)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2017
In Q3, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on Oct. 19, 2017.
Original Filing: 300910034.xml
Lobbying Issues
Autism Research programs and Autism intervention programs generally
Department of Education special education programs regarding Autism
Department of Health and Human Services programs regarding Autism, hospital acquired infections and sickle cell disease research
H.R. 3358 and S. 1771 (Departments of Labor, Health and Human Services, and Education, and related Agencies Appropriations Act, 2018), regarding autism diagnosis and treatment programs, Children's Hospital Graduate Medical Education program, National Institutes of Health and sickle cell disease
H.R. 3354 (Make America Secure and Prosperous Appropriations Act, 2018), Division F -- Departments of Labor, Health and Human Services and Education, and related agencies appropriations Act, 2018, Title II, regarding autism diagnosis and treatment programs, Children's Hospital Graduate Medical Education Program, National Institutes of Health, and sickle cell disease
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
implementation of health care reform generally pertaining to pediatric health care and autism services
Medicaid program reforms, including hospital outpatient department regulations
Section 340B Drug Pricing Program
Federal Policy regarding United Network for Organ Sharing (UNOS) and allocation of donated organs
Reauthorization of Children's Hospital Graduate Medical Education program
Sickle Cell Disease research funding generally
Reauthorization of Children's Health Insurance Program, including S. 1827 (Keep Kids' Insurance Dependable and Secure Act of 2017), all provisions
H.R. 1628 (American Health Care Act of 2017) and Senate discussions draft (Better Care Reconciliation act of 2017), all provisions and Graham-Cassidy Substitute Amendment No. 1030 to H.R. 1628, all provisions
H.R. 2430 (FDA Reauthorization Act of 2017), all provisions
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2017
In Q2, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on July 20, 2017.
Original Filing: 300895848.xml
Lobbying Issues
Autism Research programs and Autism intervention programs generally
Department of Education special education programs regarding Autism
Department of Health and Human Services programs regarding Autism, hospital acquired infections and sickle cell disease research
HR 244 (Consolidated Appropriations Act, 2017), Division H, Title II for Health and Human Services appropriations regarding autism diagnosis and treatment programs, Children's Hospital Graduate Medical Education program, National Institutes of Health, and Sickle Cell disease
FY '18 Health and Human Services appropriations regarding Autism diagnosis and treatment programs, Children's Hospital Graduate Medical Education program, National Institutes of Health and Sickle Cell Disease
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
implementation of health care reform generally pertaining to pediatric health care and autism services
Medicaid program reforms, including hospital outpatient department regulations
Section 340B Drug Pricing Program
Federal Policy regarding United Network for Organ Sharing (UNOS) and allocation of donated organs
Reauthorization of Children's Hospital Graduate Medical Education program
Sickle Cell Disease research funding generally
Reauthorization of Children's Health Insurance Program
H.R. 1628 (American Health Care Act of 2017) and Senate discussions draft (Better Care Reconciliation act of 2017), all provisions
HR 767 (SOAR to Health and Wellness Act of 2017), All provisions
Cybersecurity and information sharing guidelines pertaining to health care
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2017
In Q1, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on April 19, 2017.
Original Filing: 300870080.xml
Lobbying Issues
Autism research programs and autism intervention programs generally
Department of Education Special Education programs regarding autism
Department of Health and Human Services programs regarding autism,hospital acquired infections, and sickle cell disease research
FY '17 Health and Human Services appropriations regarding autism diagnosis and treatment programs, Children's Hospital Graduate Medical Education program, National Institutes Of Health, and Sickle Cell disease
FY '18 Health and Human Services appropriations regarding autism diagnosis and treatment programs, Children's Hospital Graduate Medical Education program, National Institutes Of Health, and Sickle Cell disease
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
implementation of health care reform generally pertaining to pediatric health care and autism services
Medicaid program reforms, including hospital outpatient department regulations
Section 340B Drug Pricing Program
Federal Policy regarding United Network for Organ Sharing (UNOS) and allocation of donated organs
Reauthorization of Children's Hospital Graduate Medical Education program
Sickle Cell Disease research funding generally
Reauthorization of Children's Health Insurance Program
H.R. 1628 (American Health Care Act of 2017), entire bill
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2016
Children's Healthcare of Atlanta amended a lobbying report for in-house lobbying in Q42016 on Feb. 1, 2017
Original Filing: 300859749.xml
Lobbying Issues
Autism Research programs and autism intervention programs generally
department of Education special education programs regarding autism
department of health and human services programs regarding autism, hospital acquired infections, sickle cell disease research and pediatric research
H.R. 5926 and S. 3040 (department of Labor, Health and Human Services, and Education, and related agencies appropriations Act, 2017), Title II, regarding Autism diagnosis and Treatment programs, Children's Hospital Graduate Medical Education program, National Institutes of Health, and sickle cell disease
H.R. 2028 (further continuing and security assistance appropriations act, 2017), regarding department of Health and Human Services funding generally
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Implementation of Health care reform generally pertaining to pediatric healthcare and autism services
Medicaid program reforms, including hospital outpatient department regulations
H.R. 546 and S.298 (ACE Kids Act of 2015), all provisions
Section 340B Drug Pricing program
H.R. 6 and H.R. 34(21st century cures Act), entire bill and senate companion FDA reform legislation generally
Stark Law Reform generally
H.R. 5273 (Helping Hospitals Improve Patient Care Act of 2016), Section 201, regarding hospital outpatient departments
Hospital Outpatient Prospective payment system regulations regarding hospital outpatient department regulations
Federal Policy regarding United Network for Organ Sharing (UNOS) and allocation of donated organs
Re-authorization of Children's Hospital Graduate Medical Education program
Sickle Cell Disease research funding generally
re-authorization of Children's Health Insurance Program
Pediatric cancer research generally
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2016
In 4A, Children's Healthcare of Atlanta did no lobbying for itself. The report was filed on Jan. 30, 2017.
Original Filing: 300859473.xml
4th Quarter, 2016
In Q4, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on Jan. 19, 2017.
Original Filing: 300849765.xml
Lobbying Issues
Autism Research programs and autism intervention programs generally
department of Education special education programs regarding autism
department of health and human services programs regarding autism, hospital acquired infections and sickle cell disease research
H.R. 5926 and S. 3040 (department of Labor, Health and Human Services, and Education, and related agencies appropriations Act, 2017), Title II, regarding Autism diagnosis and Treatment programs, Children's Hospital Graduate Medical Education program, National Institutes of Health, and sickle cell disease
H.R. 2028 (further continuing and security assistance Appropriations act, 2017), regarding department of Health and Human Services funding generally
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Implementation of Health care reform generally pertaining to pediatric healthcare and autism services
Medicaid program reforms, including hospital outpatient department regulations
H.R. 546 and S.298 (ACE Kids Act of 2015), all provisions
Section 340B Drug Pricing program
H.R. 6 and H.R. 34(21st century cures Act), entire bill and senate companion FDA reform legislation generally
Stark Law Reform generally
H.R. 5273 (Helping Hospitals Improve Patient Care Act of 2016), Section 201, regarding hospital outpatient departments
Hospital Outpatient Prospective payment system regulations regarding hospital outpatient department regulations
Federal Policy regarding United Network for Organ Sharing (UNOS) and allocation of donated organs
Reauthorization of Children's Hospital Graduate Medical Education program
Sickle Cell disease research funding generally
Reauthorization of Children's Health Insurance Program
Pediatric cancer research generally
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2016
In Q3, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on Oct. 20, 2016.
Original Filing: 300834897.xml
Lobbying Issues
Autism Research programs and autism intervention programs generally
department of Education special education programs regarding autism
department of health and human services programs regarding autism, hospital acquired infections, sickle cell disease research and pediatric research
H.R. 5926 and S. 3040 (department of Labor, Health and Human Services, and Education, and related agencies appropriations Act, 2017), Title II, regarding Autism diagnosis and Treatment programs, Children's Hospital Graduate Medical Education program, National Institutes of Health, and sickle cell disease
H.R. 5325 (Continuing Appropriations and Military Construction, Veterans Affairs, and related Agencies Appropriations act, 2017, and Zika response and Preparedness act), Division C, regarding Department of Health and Human Services funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Implementation of Health care reform generally pertaining to pediatric healthcare and autism services
Medicaid program reforms, including hospital outpatient department regulations
H.R. 546 and S.298 (ACE Kids Act of 2015), all provisions
Section 340B Drug Pricing program
H.R. 6 (21st century cures Act), entire bill and senate companion FDA reform legislation generally
Stark Law Reform generally
H.R. 5273 (Helping Hospitals Improve Patient Care Act of 2016), Section 201, regarding hospital outpatient departments
H.R. 1807 (Sickle Cell Disease research, Surveillance, Prevention, and treatment Act of 2015), entire bill
Hospital Outpatient Prospective payment system regulations regarding hospital outpatient department regulations
Federal Policy regarding United Network for Organ Sharing (UNOS) and allocation of donated organs
Reauthorization of Children's Hospital Graduate Medical Education program
S.2873 and H.R.5395 (Expanding Capacity for Health Outcomes Act), all provisions
S.1878 and H.R.1537 (Advancing Hope Act), all provisions
S.Res.592 (A resolution expressing support for the designation of the month of September 2016 as "Sickle Cell Disease Awareness Month"), all provisions
Centers for Medicare & Medicaid Services Patient Billing Issues
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2016
In 2A, Children's Healthcare of Atlanta did no lobbying for itself. The report was filed on July 28, 2016.
Original Filing: 300822887.xml
2nd Quarter, 2016
In Q2, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on July 19, 2016.
Original Filing: 300814274.xml
Lobbying Issues
Implementation of health care reform generally pertaining to pediactric health care and autism services
Medicaid program reforms, including hospital outpatient department regulations
H.R. 546 and S. 298 (ACE Kids Act of 2015), all provisions
Section 340B Drug Pricing Program
H.R. 6 (21st Century Cures Act),entire bill and Senate companion FDA reform legislation generally
H.R. 5273 (Helping Hospitals Improve Patient Care Act of 2016), Section 201, regarding hospital outpatient departments
H.R. 1807 (Sickle Cell Disease Research, Surveillance, Prevention and Treatment Act of 2015), entire bill
S. 2614 (Kevin and Avonte's Law of 2016), entire bill
H.R. 4725 (Common Sense Savings Act of 2016), section 4, regarding provider taxes
Pediatric oncology research and the Pediatric Research Equity Act of 2003 (PREA)
Organ Procurement and Transplantation Network (OPTN), liver redistricting proposal
S.2041/H.R.5182 (Promoting Life-Saving New Therapies for Neonates Act of 2015), all provisions
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Autism research programs and autism intervention programs generally
Department of Education special education programs regarding autism
Department of Health and Human Services program regarding autism, hospital acquired infections and sickle cell disease research
FY'16 Department of Health and Human Services appropriations, regarding cancer research funding
S. 3040 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017), Title II, regarding autism diagnosis and treatment programs, Children's Hospital Graduate Medical Education program, National Institutes of Health, and sickle cell disease
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2016
In Q1, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on April 20, 2016.
Original Filing: 300798091.xml
Lobbying Issues
Implementation of health care reform generally pertaining to pediactric health care and autism services
Medicaid program reforms, including hospital outpatient department regulations
H.R. 546 and S. 298 (ACE Kids Act of 2015), all provisions
Section 340B Drug Pricing Program
ICD-10 Codes Implementation Program
H.R. 6 (21st Century Cures Act),entire bill and Senate companion FDA reform legislation generally
S. 1878 (Advancing Hope Act of 2016), all provisions
S.1446 (SOAR to Health and Wellness Act of 2015), all provisions
S.2041 (Promoting Life-Saving New Therapies for Neonates Act of 2015), all provisions
S.2248/H.R.3952 (Congenital Heart Futures Reauthorization Act of 2015), all provisions
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Department of Defense funding for autism research and diagnosis services generally
Autism research programs and autism intervention programs generally
Department of Education special education programs regarding autism
Department of Health and Human Services program regarding autism, hospital acquired infections and sickle cell disease research
FY'16 Department of Health and Human Services appropriations, regarding cancer research funding
FY'17 Department of Health and Human Services Appropriations, regarding autism diagnosis and treatment programs, Children's Hospital Graduate Medical Education program, National Institutes of Health, Sickle Cell Disease
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2015
In Q4, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on Jan. 20, 2016.
Original Filing: 300778298.xml
Lobbying Issues
Implementation of health care reform generally pertaining to pediactric health care and autism services
Medicaid program reforms, including hospital outpatient department regulations
H.R. 546 and S. 298 (ACE Kids Act of 2015), all provisions
Section 340B Drug Pricing Program
ICD-10 Codes Implementation Program
H.R. 6 (21st Century Cures Act), all provisions
Regulations Regarding liver transplantation allocation methods
H.R. 1859 (Ensuring Children's Access to Specialty Care Act of 2015), all provisions
S. 2041 (Promoting Life-Saving New Therapies for Neonates Act of 2015), all provisions
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Department of Defense funding for autism research and diagnosis services generally
Autism research programs and autism intervention programs generally
Department of Education special education programs regarding autism
Department of Health and Human Services program regarding autism
H.R. 2029 (Consolidated Appropriations Act, 2016) Division H, Titles II and III, regarding autism diagnosis and treatment programs, Children's Hospital Graduate Medical Education Program, National Institutes of Health
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2015
Children's Healthcare of Atlanta amended a lobbying report for in-house lobbying in Q32015 on Jan. 29, 2016
Original Filing: 300785642.xml
Lobbying Issues
Implementation of health care reform generally pertaining to pediactric health care and autism services
Medicaid program reforms
H.R. 546 and S. 298 (ACE Kids Act of 2015), all provisions
Section 340B Drug Pricing Program
ICD-10 Codes Implementation Program
H.R. 2652(Protecting Patients and Physicians Against Coding Act of 2015). all provisions
H.R. 2126 (Cutting Costlly Codes Act of 2015), All provisions
H.R. 6 (21st Century Cures Act), all provisions
Childhood Cancer STAR Act (draft bill) regarding cancer research, all provisions
H.R. 3018(Code-FLEX Act of 2015), all provisions
H.R. 2515 (Anna Westin Act of 2015), all provisions
Regulations Regarding liver transplantation allocation methods
H.R. 2820 (Stem cell therapeutic and research reauthorization Act of 2015), all provisions
US Preventative Services Task Force draft recommendation on autism screening
Sickle Cell Awareness
Cardiomyopathy Awareness
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Department of Defense funding for autism research and diagnosis services generally
Autism research programs and autism intervention programs generally
Department of Education special education programs regarding autism
Department of Health and Human Services program regarding autism
H.R. 3020 and S. 1695(departments of Labor, Health and Human Services, and Education, and related Agencies Appropriations Act 2016)
(Titles II and III) regarding autism diagnosis and treatment programs, Children's Hospital Graduate Medical Education Program, National Institutes of Health
H.R. 719 (Continuing Appropriations Act, 2016), all provisions
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2015
In Q3, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on Oct. 20, 2015.
Original Filing: 300760382.xml
Lobbying Issues
Implementation of health care reform generally pertaining to pediactric health care and autism services
Medicaid program reforms
H.R. 546 and S. 298 (ACE Kids Act of 2015), all provisions
Section 340B Drug Pricing Program
ICD-10 Codes Implementation Program
H.R. 2652(Protecting Patients and Physicians Against Coding Act of 2015). all provisions
H.R. 2126 (Cutting Costlly Codes Act of 2015), All provisions
H.R. 6 (21st Century Cures Act), all provisions
Childhood Cancer STAR Act (draft bill) regarding cancer research, all provisions
H.R. 3018(Code-FLEX Act of 2015), all provisions
H.R. 2515 (Anna Westin Act of 2015), all provisions
Regulations Regarding liver transplantation allocation methods
H.R. 2820 (Stem cell therapeutic and research reauthorization Act of 2015), all provisions
US Preventative Services Task Force draft recommendation on autism screening
Sickle Cell Awareness
Cardiomyopathy Awareness
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Department of Defense funding for autism research and diagnosis services generally
Autism research programs and autism intervention programs generally
Department of Education special education programs regarding autism
Department of Health and Human Services program regarding autism
H.R. 3020 and S. 1695(departments of Labor, Health and Human Services, and Education, and related Agencies Appropriations Act 2016)
(Titles II and III) regarding autism diagnosis and treatment programs, Children's Hospital Graduate Medical Education Program, National Institutes of Health
H.R. 719 (Continuing Appropriations Act, 2016), all provisions
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2015
In Q2, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on July 20, 2015.
Original Filing: 300744037.xml
Lobbying Issues
Implementation of health care reform generally pertaining to pediactric health care and autism services
Medicaid program reforms
H.R. 546 and S. 298 (ACE Kids Act of 2015), all provisions
H.R. 2 (Medicare Access and CHIP Reauthorization Act of 2015)(Title III), Children's Health Insurance Program (CHIP)
reauthorization provisions,Section 340B Drug Pricing Program
ICD-10 Codes Implementation Program
H.R. 2652 (Protecting Patients and Physicians against coding Act og 2015), all provisions
H.R. 2126 (Cutting Costly Codes Act of 2015), all provisions
H.R. 6 (21st Century Cures Act), all provisions
Childhood Cancer STAR Act (draft bill) regarding Cancer research, all provisions
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Department of Defense funding for autism research and diagnosis services generally
Autism research programs and autism intervention programs generally
Department of Education special education programs regarding autism
Department of Health and Human Services program regarding autism
S. 1695 and house Companion bill (departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016)
(Titles II and III) regarding autism diagnosis and treatment programs, Children's Hospital Graduate Medical Education program, National Institutes of Health
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2015
Children's Healthcare of Atlanta amended a lobbying report for in-house lobbying in Q22015 on July 20, 2015
Original Filing: 300744841.xml
Lobbying Issues
Implementation of health care reform generally pertaining to pediactric health care and autism services
Medicaid program reforms
H.R. 546 and S. 298 (ACE Kids Act of 2015), all provisions
H.R. 2 (Medicare Access and CHIP Reauthorization Act of 2015)(Title III), Children's Health Insurance Program (CHIP)
reauthorization provisions,Section 340B Drug Pricing Program
ICD-10 Codes Implementation Program
H.R. 2652(Protecting Patients and Physicians Against Coding Act of 2015). all provisions
H.R. 2126 (Cutting Costlly Codes Act of 2015), All provisions
H.R. 6 (21st Century Cures Act), all provisions
Childhood Cancer STAR Act (draft bill) regarding cancer research, all provisions
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Department of Defense funding for autism research and diagnosis services generally
Autism research programs and autism intervention programs generally
Department of Education special education programs regarding autism
Department of Health and Human Services program regarding autism
S. 1695 and house Companion bill (departments of Labor, Health and Human Services, and Education, and related Agencies Appropriations Act 2016)
(Titles II and III) regarding autism diagnosis and treatment programs, Children's Hospital Graduate Medical Education Program, National Institutes of Health
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2015
In Q1, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on April 20, 2015.
Original Filing: 300725783.xml
Lobbying Issues
Implementation of health care reform generally pertaining to pediactric health care and autism services
Medicaid program reforms
H.R. 546 and S. 298 (ACE Kids Act of 2015), all provisions
H.R. 2 (Medicare Access and CHIP Reauthorization Act of 2015)(Title III), Children's Health Insurance Program (CHIP)
reauthorization provisions,Section 340B Drug Pricing Program
ICD-10 Codes Implementation Program
Agencies Lobbied
U.S. House of Representatives U.S. Senate Executive Office of the President (EOP)
Lobbying Issues
Department of Defense funding for autism research and diagnosis services generally
Autism research programs and autism intervention programs generally
Department of Education special education programs regarding autism
Department of Health and Human Services program regarding autism
FY '16 federal spending on autism diagnosis and treatment programs generally
FY '16 funding regarding Children's Hospital Graduate Medical Education program
Agencies Lobbied
U.S. Senate U.S. House of Representatives Executive Office of the President (EOP)
4th Quarter, 2014
In Q4, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on Jan. 20, 2015.
Original Filing: 300705308.xml
Lobbying Issues
Implementation of health care reformgenerally pertaining to pediatric health care and autism services
Medicaid program reforms
H.R. (ACE Kids Act of 2014), all provisions
Children's Health Insurance Program (CHIP) reauthorization
Issues related to hospitals, healthcare systems and Medicare/Medicaid payments
ACA Implementation Issues
H.R. 297, Children's Hospital GME Support Reauthorization Act of 2013/S. 1557
H.R. 2810, Medicare Patient Access and Quality Improvement Act 2013
Proposals related to the Sustainable Growth Rate
Issues Related to the 340B Program
Telehealth Issues
UNOS Liver Transplant Process Reform
H.R., 4930, Latest Title: ACE Kids Act of 2014
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Issues related to Medicaid Reform
H.R., 4015, SGR Repeal and Medicare Provider Payment Modernization Act of 2014
S. 2000, SGR Repeal and Medicare Provider Payment Modernization Act of 2014
H.R. 4302, Protecting Access to Medicare Act of 2014
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Medicaid and Children's Hospital Related funding
S. 1284, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2014
CHGME Funding Levels in Labor HHS Ed Appropriation Bill
Issues Related to Delayed Language on Liver Transplants in Labor HHS Ed Appropriation Bill
Department of Defense funding for autism research and diagnosis services generally
H.R. 4435 and S. 2410 (National Defense Authorization Act for Fiscal Year 2015) (Title VII), regarding funding for autism research and diagnosis services
Autism research program and autism intervention programs generally
Department of Education special education programs regarding autism
Department of Health and Human Services programs regarding autism
H.R. 83 (Consolidated and Further Continuing Appropriations Act, 2015) (Division G, Title II) regarding Children's Hospitals
Graduate Medical Education program funding
FY '16 Federal spending and autism diagnosis and treatment programs generally
NIH/Research Funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2014
In Q3, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on Oct. 20, 2014.
Original Filing: 300686551.xml
Lobbying Issues
Issues related to hospitals, healthcare systems and Medicare/Medicaid payments
ACA Implementation Issues
H.R. 297, Children's Hospital GME Support Reauthorization Act of 2013/S. 1557
H.R. 2810, Medicare Patient Access and Quality Improvement Act 2013
Implementation of healthcare reform generally pertaining to pediatric healthcare and autism services
Medicaid program reforms
Issues Related to the 340B Program
Telehealth Issues
UNOS Liver Transplant Process Reform
H.R. 4631 and S. 2449 (Autism CARES Act of 2014), all provisions
H.R. 4930 (ACE Kids Act of 2014), all provisions
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Issues related to Medicaid Reform
H.R. 4015, Medicare Provider Payment Modernization Act of 2014
S. 2000, Medicare Provider Payment Modernization Act of 2014
H.R. 4302, Protecting Access to Medicare Act of 2014
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Medicaid and Children's Hospital Related Funding
S. 1284, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2014
CHGME Funding Levels in Labor HHS ED Appropriation Bill
Issues Related to Delayed Language of Liver Transplants in Labor HHS Ed Appropriations Bill
FY '14 Department of Defense grant funding for autism research and diagnosis services
H.R. 4435 and S. 2410 (National Defense Authorizatoin Act for Fiscal Year 2015) (Title VII), regarding funding for autism research and diagnosis services
Autism research programs and autism intervention programs generally
Department of Education special education programs regarding autism
Department of Health and Human Services programs regarding autism
NIH/Research Funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives Office of Management & Budget (OMB)
2nd Quarter, 2014
Children's Healthcare of Atlanta amended a lobbying report for in-house lobbying in Q22014 on Jan. 15, 2016
Original Filing: 300772470.xml
Lobbying Issues
Issues related to hospitals, healthcare systems and Medicare/Medicaid payments
ACA Implementation Issues
H.R. 297, Children's Hospital GME Support Reauthorization Act of 2013/S. 1557
H.R. 2810 Medicare Patient Access and Quality Improvement Act of 2013
SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013
Proposals related to the Sustainable Growth Rate
Issues related to teh 340B Program
Telehealth Issues
UNOS Liver Transplant Process Reform
Implementation of healthcare reform generally pertaining to pediatric healthcare and autism services
Medicaid program reforms
S. 1557 (Children's Hospital GME Support Reauthorization Act of 2013), all provisions
H.R. 4631 and S. 2449 (Autism CARES Act of 2014), all provisions
H.R. 4930 (ACE Kids Act of 2014), all provisions
Agencies Lobbied
U.S. House of Representatives Health & Human Services - Dept of (HHS) U.S. Senate
Lobbying Issues
Medicaid and Children's Hospital Related funding
S. 1284, Departments of Labor, Health and Human Services, and Education, and Related Agencies Approprations Act, 2014
CHGME Funding Levels in Labor HHS ED Appropriation Bill
Issues Related to Delayed Language on Liver Transplants in Labor HHS ED Appropriation Bill
FY '14 Department of Defense grant funding for autism research and diagnosis services
H.R. 4435 and S. 2410 (National Defense Authorization Act for Fiscal Year 2015) (Title VII), regarding funding for autism research and diagnosis services
Autism research programs and autism intervention programs generally
Department of Education special education programs regarding autism
Department of Health and Human Services programs regarding autism
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues related to Medicaid Reform
H.R. 4015, SGR Repeal and Medicare Provider Payment Modernization Act of 2014
S. 2000, SGR Repeal and Medicare Provider Payment Modernization Act of 2014
H.R. 4302, Protecting Access to Medicare Act of 2014
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2014
In Q2, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on July 17, 2014.
Original Filing: 300658782.xml
Lobbying Issues
Issues related to hospitals, healthcare systems and Medicare/Medicaid payments
ACA Implementation Issues
H.R. 297, Children's Hospital GME Support Reauthorization Act of 2013/S. 1557
H.R. 2810 Medicare Patient Access and Quality Improvement Act of 2013
SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013
Proposals related to the Sustainable Growth Rate
Issues related to teh 340B Program
Telehealth Issues
UNOS Liver Transplant Process Reform
Implementation of healthcare reform generally pertaining to pediatric healthcare and autism services
Medicaid program reforms
S. 1557 (Children's Hospital GME Support Reauthorization Act of 2013), all provisions
H.R. 4631 and S. 2449 (Autism CARES Act of 2014), all provisions
H.R. 4930 (ACE Kids Act of 2014), all provisions
Agencies Lobbied
U.S. House of Representatives Health & Human Services - Dept of (HHS) U.S. Senate
Lobbying Issues
Medicaid and Children's Hospital Related funding
S. 1284, Departments of Labor, Health and Human Services, and Education, and Related Agencies Approprations Act, 2014
CHGME Funding Levels in Labor HHS ED Appropriation Bill
Issues Related to Delayed Language on Liver Transplants in Labor HHS ED Appropriation Bill
FY '14 Department of Defense grant funding for autism research and diagnosis services
H.R. 4435 and S. 2410 (National Defense Authorization Act for Fiscal Year 2015) (Title VII), regarding funding for autism research and diagnosis services
Autism research programs and autism intervention programs generally
Department of Education special education programs regarding autism
Department of Health and Human Services programs regarding autism
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues related to Medicaid Reform
H.R. 4015, SGR Repeal and Medicare Provider Payment Modernization Act of 2014
S. 2000, SGR Repeal and Medicare Provider Payment Modernization Act of 2014
H.R. 4302, Protecting Access to Medicare Act of 2014
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2014
In Q1, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on April 21, 2014.
Original Filing: 300644287.xml
Lobbying Issues
Implementation of healthcare reform generally pertaining to pediatric healthcare and autism services
Issues related to hospitals, healthcare systems and Medicaid payments
H.R. 297, Children's Hospital GME Support Reauthorization Act of 2013/S. 1557
SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013
Proposals related to the Sustainable Growth Rate
340B Issues
Telehealth Issues
Agencies Lobbied
U.S. House of Representatives Health & Human Services - Dept of (HHS) U.S. Senate
Lobbying Issues
Issues related to Medicaid Reform
Sustainable Growth Rate Proposals
Agencies Lobbied
U.S. House of Representatives Health & Human Services - Dept of (HHS) U.S. Senate
Lobbying Issues
Medicaid and Children's Hospital Related funding
S. 1284, Department of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2014
CHGME Funding Levels in Labor HHS Ed Appropriation Bill
FY '14 Department of Defense grant funding for Autism research and diagnosis services
Department of Health and Human Services programs regarding autism
National Defense Authorization Ace for Fiscal Year 2015 regarding funding for autism research and diagnosis services
Autism research programs and autism intervention programs generally
Department of Education special education programs regarding autism
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Tele-Nutrition and Obesity Programs
S. 954, Agriculture Reform, Food, and Jobs Act of 2013
H.R. 1947, Federal Agriculture Reform and Risk Management Act of 2013
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2013
In Q4, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on Jan. 20, 2014.
Original Filing: 300620980.xml
Lobbying Issues
Issues related to hospitals, healthcare systems and Medicare/Medicaid payments
ACA Implementation Issues
H.R. 297, S.1557 Children's Hospital GME Support Reauthorization Act of 2013, all provisions
Medicaid program reformsImplementation of health care reform generally pertaining to pediatric health care and autism
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
Issues related to Medicaid Reform
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
Medicaid and Children's Hospital Related funding
S. 1284, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2014
CHGME Funding Levels in Labor HHS Ed Appropriation Bills
FY '14 Department of Defense grant funding for autism research and diagnosis servicesH.R. 1960, H.R. 3304 and S. 1197 (National Defense Authorization Act for Fiscal Year 2014) regarding funding for autism research and diagnosis services (Division A, Title VII)
FY '14 (H.R. 2397) Department of Defense Appropriations regarding funding for autism research and diagnosis services (Title IX)
Autism research programs and autism intervention programs generally
Department of Education special education programs regarding autism
Department of Health and Human Services programs regarding autism
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2013
In Q3, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on Oct. 18, 2013.
Original Filing: 300600123.xml
Lobbying Issues
Implementation of healthcare reform, issues generally pertaining to pediatric health care hospitals and health care systems and autism services. Medicaid program reform. HR 297 and S1557 Childrens Hospital GME Support Reauthorization Act of 2013, all provisions.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS)
Lobbying Issues
FY13 Department of Defense grant funding for autism research and diagnosis services; HR 1960 and S1197 (NDAAFY14) regarding funding for autism research and diagnosis services (Division A, Title VII); FY14 (HR 2397) Department of Defense Appropriations regarding funding for autism research and diagnosis services (Title IX); Medicaid and Children's Hospital Related Funding; Departments of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, 2014, CHGME Funding Levels in Labor HHS Ed Appropriations Bills;
Autism Research Programs
Department of Education special education programs regarding autism
Department of Health and Human Services programs regarding autism
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Issues relating to Medicaid Reform
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS)
Lobbying Issues
Tele-nutrition and Obesity Programs; S. 954, Agriculture Reform, Food and Jobs Act of 2013; HR1947, Federal Agriculture Reform and Risk Management Act of 2013
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2013
In Q2, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on July 19, 2013.
Original Filing: 300577276.xml
Lobbying Issues
Implementation of healthcare reform, issues generally pertaining to pediatric health care hospitals and health care systems and autism services. Medicaid program reform. HR 297 Children's Hospital GME Support Reauthorization Act of 2013
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS)
Lobbying Issues
FY13 Department of Defense grant funding for autism research and diagnosis services; HR 1960 and S1197 (NDAA FY14) regarding funding for autism research and diagnosis services (Division A, Title VII); FY14 (HR 2397) Department of Defense Appropriations regarding funding for autism research and diagnosis services (Title IX); Medicaid and Children's Hospital Related Funding; Labor HHS Education Appropriation Bill - No specific LegislationAutism Research Program
Department of Education special education programs regarding autism
Department of Health and Human Services program regarding autism
Agencies Lobbied
U.S. House of Representatives U.S. Senate Education - Dept of
Lobbying Issues
Issues relating to Medicaid Reform
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS)
Lobbying Issues
Telenutrition and Obesity Program; S954 Agriculture Reform, Food and Jobs Act of 2013; HR 1947, Federal Agriculture Reform and Risk Management Act of 2013
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2013
In Q1, Children's Healthcare of Atlanta had in-house lobbyists. The report was filed on April 19, 2013.
Original Filing: 300557562.xml
Lobbying Issues
Healthcare Reform & Related FY13 Budget Issues
FY13 and FY14 Labor HHS, Education Appropriations bill regarding HHS funding for CHGME. HR933 (Consolidated and further continuing appropriations act 2013) regarding pediatric healthcare and autism programs (Division F, Title V). FY13 Dept. of Def. grant funding and FY14 appropriations regarding funding for autism reserach and diagnosis services
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
S 958 and HR 1852 Children's Hospital GME Support Reauthorization Act of 2011- all provisions
FY14 Department of Defense authorization regarding autism services
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
Issues related to Hospital Healthcare system and Medicaid Policy Reform
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2013
Children's Healthcare of Atlanta filed a lobbying registration on Feb. 14, 2013 for in-house lobbying efforts, effective Jan. 3, 2013.
Original Filing: 300545532.xml
Issue(s) they said they’d lobby about: Funding and policy opportunities generally related to Autism research and care. Funding opportunities for all disciplines specifics to pediatric healthcare. Implementation of the PPACA and the HCERA 2010, EHB. Support of H.R. 297, a bill to reauthorize the CHGME program. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate